TIDMABDX

RNS Number : 2789H

Abingdon Health PLC

23 November 2022

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

Notice of Annual General Meeting and Notice of Results

York, U.K. 23 November 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests, announces that its Annual General Meeting ('AGM') will be held on Monday 19 December at 9.30 a.m. at the offices of Abingdon Health, York Biotech Campus, Sand Hutton, York, YO41 1LZ, United Kingdom. Furthermore, the Company will be releasing its preliminary results for the year ended 30 June 2022 on 24 November 2022.

The notice convening the AGM will be sent to shareholders today and is available on the Company's website www.abingdonhealth.com .

Enquiries:

 
 Abingdon Health plc                                       www.abingdonhealth.com/investors/ 
 Chris Yates, Chief Executive Officer                                        Via Walbrook PR 
 Melanie Ross , Chief Financial Officer 
 Chris Hand, Non-Executive Chairman 
 
 Singer Capital Markets (Sole Broker                                Tel: +44 (0)20 7496 3000 
  and Nominated Adviser) 
 Peter Steel, Alex Bond (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
 
 Walbrook PR Limited                     Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com 
 Paul McManus / Phillip Marriage                      Mob: +44 (0)7980 541 893 / +44 (0)7867 
  Alice Woodings                                                                     984 082 
                                                                         +44 (0)7407 804 654 
 
 

About Abingdon Health plc

Abingdon Health is a world leading developer and manufacturer of high-quality lateral flow rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.

The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx(R) , a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

Founded in 2008, Abingdon Health is headquartered in York, England.

For more information visit: www.abingdonhealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAFFFLLLTLFFIF

(END) Dow Jones Newswires

November 23, 2022 02:00 ET (07:00 GMT)

Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more Abingdon Health Charts.
Abingdon Health (LSE:ABDX)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more Abingdon Health Charts.